Beköz, H. Et Al. 2017. Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience.. Annals of oncology : official journal of the European Society for Medical Oncology , vol.28, no.10 , 2496-2502.

Beköz, H., Karadurmuş, N., Paydaş, S., Türker, A., Toptaş, T., Firatli Tuğlular, T., ... Sönmez, M.(2017). Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience.. Annals of oncology : official journal of the European Society for Medical Oncology , vol.28, no.10, 2496-2502.

Beköz, H. Et Al. "Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience.," Annals of oncology : official journal of the European Society for Medical Oncology , vol.28, no.10, 2496-2502, 2017

Beköz, H. Et Al. "Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience.." Annals of oncology : official journal of the European Society for Medical Oncology , vol.28, no.10, pp.2496-2502, 2017

Beköz, H. Et Al. (2017) . "Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience.." Annals of oncology : official journal of the European Society for Medical Oncology , vol.28, no.10, pp.2496-2502.

@article{article, author={H. Beköz Et Al. }, title={Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience.}, journal={Annals of oncology : official journal of the European Society for Medical Oncology}, year=2017, pages={2496-2502} }